1.0Division of Oncology/medicine/oncologyBradley Olson/medicine/oncology/author/bradley-olson/Ashwin Somasundaram, MD - Division of Oncologyrich600338<blockquote class="wp-embedded-content" data-secret="HbEUxqk267"><a href="/medicine/oncology/people/ashwin-somasundaram-md/">Ashwin Somasundaram, MD</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="/medicine/oncology/people/ashwin-somasundaram-md/embed/#?secret=HbEUxqk267" width="600" height="338" title="“Ashwin Somasundaram, MD” — Division of Oncology" data-secret="HbEUxqk267" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]> */
</script>
/medicine/oncology/wp-content/uploads/sites/1288/2022/02/Somasundaram-Ashwin.jpg614768Ashwin Somasundaram’s research interests are focused on understanding mechanisms of resistance and response in the tumor microenvironment from both an immunology and cancer cell biology perspective. He is focused on validating findings of checkpoint blockade resistance mechanisms found in animal models in ex vivo patient samples and in early phase clinical trials. These translational efforts … Read more